The surveillance of Haemophilus influenzae in Belgium is based on data from 3 different sources:

  1. mandatory reporting in the three regions 
  2. data from the National Reference Centre for H. influenzae 
  3. data from the network of sentinel laboratories.

For more information, see the ‘Publications’ section at the bottom of this page.

Sciensano collects data on invasive H. Influenzae infections via the network of sentinel laboratories and integrates data from other surveillance sources in order to monitor the trends of this disease and its impact on the public health of the Belgian population. This information is used to support public health decisions. Sciensano’s Belgian Official Medicines Control Laboratory (OMCL) in Sciensano is responsible, together with the European OMCL network, for the quality control of the vaccine against H. Influenzae type b before it is put on the market.


There are currently no projects associated to this health topic


There are currently no events associated to this health topic

Other sources of information

There are currently no external links associated to this health topic

In the media

There are currently no media associated to this health topic

QR code

QR code for this page URL